Aerovate Therapeutics Inc Book Value Per Share is 3.27 for the Trailing 12 Months (TTM) ending March 31, 2024, a -39.50% change year over year. The book value per share represents the net value of a company allocated to each outstanding share of common stock. It is calculated by dividing shareholders' equity by the weighted average number of shares outstanding. The book value per share provides insight into the intrinsic value of a company's shares and can be used to assess the relative value of a stock compared to its market price.